Skip to main content
HGHYX logo

The Hartford Healthcare Fd Cl Y (HGHYX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$51.59 -$0.06 (-0.12%)

Beta 0.77: the stock has moved about 23% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

The Hartford Healthcare Fd Cl Y (HGHYX) trades at $51.59. The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund focused on long-term capital appreciation through investments in global healthcare companies. Sector: Financials.

Price as of · Last analyzed: Mar 17, 2026
The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund focused on long-term capital appreciation through investments in global healthcare companies. It invests across various healthcare subsectors, including pharmaceuticals, biotechnology, and medical services.

Analyst Coverage for HGHYX: HGHYX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the HGHYX film Every key number, told as a short cinematic story — just press play. ~2 min

The Hartford Healthcare Fd Cl Y (HGHYX) Financial Services Profile

IPO Year2000

The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund with an $0.85 billion market cap, strategically investing in a diverse portfolio of global healthcare companies. Managed by Wellington Management, the fund targets long-term capital appreciation across pharmaceuticals, biotechnology, and medical services, offering investors exposure to the healthcare sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for HGHYX?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The Hartford Healthcare Fd Cl Y presents an investment opportunity for those seeking exposure to the global healthcare sector with a focus on long-term capital appreciation. With a beta of 0.77, the fund exhibits lower volatility compared to the broader market, potentially offering a more stable investment option. The fund's strategy of investing at least 80% of its assets in healthcare equities, managed by Wellington Management, provides access to a diversified portfolio across various healthcare subsectors. Key growth catalysts include the aging global population, advancements in medical technology, and increasing healthcare spending worldwide. However, investors may want to evaluate potential risks such as regulatory changes, competition within the healthcare industry, and market fluctuations. While the fund does not offer a dividend yield, its focus on capital appreciation may appeal to investors seeking long-term growth.

Based on FMP financials and quantitative analysis

HGHYX Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The Hartford Healthcare Fd Cl Y has a market capitalization of $0.85 billion, indicating a mid-sized fund within the asset management landscape.

  • The fund's beta of 0.77 suggests lower volatility compared to the overall market, potentially offering a more stable investment experience.
  • The fund invests at least 80% of its assets in equity securities of healthcare-related companies worldwide, demonstrating a focused approach to the healthcare sector.
  • Wellington Management Company LLP serves as the sub-adviser, bringing expertise in healthcare investing to the fund's management.
  • The fund's investment strategy encompasses a broad range of healthcare subsectors, including pharmaceuticals, biotechnology, and medical services, providing diversification within the healthcare industry.

Who Are HGHYX's Competitors?

HGHYX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
AOGIX American Century One Choice Portfolio: Aggressive Investor Class $18.36 +0.71% $893M —
AREVX American Century Investments One Choice 2055 Portfolio $18.48 +0.65% $731M —
BASAX Brown Advisory Small Cap Growth Adv Shares $20.51 +1.08% $584M —
BCSAX BlackRock Commodity Strategies Portfolio $11.21 -0.27% $1.27B —
BIASX Brown Advisory Small-Cap Growth Fd Investor Shs $21.86 +1.11% $584M —
BLK BlackRock, Inc. $1059.63 -0.44% $164B 49 5-pillar
BX Blackstone Inc. $111.74 -0.45% $135B 67 5-pillar
APOS Apollo Global Management, Inc. $25.59 -0.23% $74.8B 55 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HGHYX's Key Strengths?

Experienced sub-adviser (Wellington Management).

  • Diversified portfolio across healthcare subsectors.
  • Global investment scope.
  • Focus on long-term capital appreciation.

What Are HGHYX's Weaknesses?

No dividend yield.

  • Reliance on the performance of the healthcare sector.
  • Potential for regulatory changes to impact investments.
  • Susceptibility to market fluctuations.

What Are the Key Risks for HGHYX?

Regulatory changes impacting the healthcare industry.

  • Economic downturns reducing healthcare spending.
  • Competition within the healthcare sector.
  • Market fluctuations affecting the value of investments.

What Threats Does HGHYX Face?

  • Competition from other healthcare-focused funds.
  • Economic downturns impacting healthcare spending.
  • Regulatory changes affecting the healthcare industry.
  • Patent expirations and generic drug competition.

What Are HGHYX's Competitive Advantages?

  • Expertise of Wellington Management Company LLP in healthcare investing.
  • Diversified portfolio across various healthcare subsectors.
  • Global investment scope providing access to opportunities in both developed and emerging markets.

What Does HGHYX Do?

The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund managed with the objective of achieving long-term capital appreciation. The fund operates by investing primarily in the equity securities of healthcare-related companies located worldwide. This investment strategy is executed under the guidance of Wellington Management Company LLP, the sub-adviser, which selects companies across a broad spectrum of the healthcare sector. The fund's approach is comprehensive, encompassing investments in various subsectors such as pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services, and emerging health-related areas. The fund's investment mandate requires that at least 80% of its assets be allocated to the equity securities of these healthcare companies. This concentration reflects a focused approach to capitalizing on the growth potential within the healthcare industry. By diversifying across different segments within healthcare, the fund aims to mitigate risk while capturing opportunities for capital appreciation. The fund's global investment scope allows it to access healthcare companies in both developed and emerging markets, further diversifying its portfolio and potentially enhancing returns. The Hartford Healthcare Fd Cl Y provides investors with a vehicle to participate in the growth of the healthcare sector through a professionally managed fund with a broad and diversified investment strategy.

What Products and Services Does HGHYX Offer?

  • Invests in equity securities of healthcare-related companies worldwide.
  • Targets long-term capital appreciation.
  • Allocates at least 80% of its assets to healthcare equities.
  • Diversifies investments across various healthcare subsectors.
  • Operates under the guidance of Wellington Management Company LLP.
  • Provides investors with exposure to the global healthcare sector.

How Does HGHYX Make Money?

  • The fund generates revenue through capital appreciation of its investments in healthcare companies.
  • It charges management fees to investors for managing the fund's assets.
  • The fund's performance is influenced by the performance of the healthcare sector and the specific companies it invests in.

What Industry Does HGHYX Operate In?

The Hartford Healthcare Fd Cl Y operates within the asset management industry, specifically focusing on the healthcare sector. The global healthcare market is experiencing growth driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The fund competes with other healthcare-focused funds, such as AOGIX, AREVX, BASAX, BCSAX, and BIASX, in attracting investor capital. The competitive landscape is characterized by varying investment strategies, expense ratios, and fund performance. HGHYX aims to differentiate itself through its broad approach to healthcare investing and the expertise of its sub-adviser, Wellington Management.

Who Are HGHYX's Key Customers?

  • Individual investors seeking exposure to the healthcare sector.
  • Institutional investors looking for long-term capital appreciation.
  • Retirement savers seeking diversified investment options.
Model self-rating on this text: 80% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is a fund, not an operating company

HGHYX Financials

Bull Case vs Bear Case

Bull Case

  • Experienced sub-adviser (Wellington Management).
  • Diversified portfolio across healthcare subsectors.
  • Global investment scope.
  • Focus on long-term capital appreciation.

Bear Case

  • No dividend yield.
  • Reliance on the performance of the healthcare sector.
  • Potential for regulatory changes to impact investments.
  • Susceptibility to market fluctuations.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

HGHYX Latest News

No recent news available for HGHYX.

HGHYX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HGHYX.

Price Targets

Wall Street price target analysis for HGHYX.

HGHYX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for HGHYX; grades run from A+ (80-100) to F (below 30).

Common Questions About HGHYX (Financials)

How does HGHYX incorporate ESG (Environmental, Social, and Governance) factors into its investment decisions?

While specific ESG integration details for HGHYX are not provided, it is increasingly common for asset managers to consider ESG factors in their investment processes.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on available information and may not be fully comprehensive.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis